CytoMed Therapeutics Limited (GDTC) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
CytoMed Therapeutics Limited has announced changes to its Board of Directors, with Dr. Lucas Luk and Mr. Wu Tao Thomas resigning for personal reasons, not related to company operations or practices. Dr. Luk will continue as Chief Clinical Officer and join the board of a subsidiary, while Dr. Loh Yuin Han steps in to ensure the audit committee maintains its required number of independent directors.
For further insights into GDTC stock, check out TipRanks’ Stock Analysis page.